Stroke Outcome in Pregnancy and Preeclampsia

妊娠期和先兆子痫的中风结果

基本信息

项目摘要

PROJECT SUMMARY Stroke in pregnancy is a major health problem in the US, with an incidence that is 3-fold higher than stroke rates in comparable nonpregnant women. Pregnancy-related stroke has a profound and devastating impact on a women’s life and her ability to care for her child or children. Complicating the public health concerns even more is the fact pregnancy-related strokes in the United States is on the rise. The increased risk of stroke in pregnancy is largely driven by the comorbidity of preeclampsia (PE), a hypertensive disorder that complicates up to 10% of all pregnancies. In fact, greater than 1/3 of women with pregnancy-related stroke have comorbid PE, increasing the risk of stroke 6-fold vs. women without PE. Relevant to this proposal, stroke in pregnancy is largely unstudied. Pregnant women have been excluded from randomized stroke clinical trials and therefore nothing is known about treatment and outcome in this population. This R21 proposal is to provide critically needed information on stroke injury and outcome in pregnancy and PE. Our overall hypothesis is that the maternal brain is more susceptible to ischemia and reperfusion injury than age-matched nonpregnant females and that this susceptibility is further exacerbated by PE. This hypothesis is based on our published and preliminary data demonstrating increased neuronal excitability and brain injury in a rat model of normal pregnancy that is further increased in a model of PE. In addition, PE is a state of high oxidative stress and neuroinflammation that could exacerbate stroke injury. Remarkably, it is unknown how pregnancy and PE affect stroke outcome. Aim 1 will use a model of transient focal ischemia in nonpregnant, normal pregnant and PE rats to determine stroke outcome (infarct, cellular injury, neurologic deficit and mortality) as well as contributors to injury, including perfusion deficit, collateral flow and reperfusion injury (edema and hemorrhagic transformation). Aim 2 will acutely treat with clinically relevant doses of magnesium sulfate (MgSO4), a safe and effective treatment in pregnancy that has been used for decades to prevent brain hyperexcitability and seizure. MgSO4 is a calcium antagonist that prevents glutamate-induced excitotoxic injury and may be beneficial in preventing stroke injury in pregnancy and PE, an excitotoxic state. Importantly, we will use MgSO4 in combination with tissue plasminogen activator (tPA) since tPA has been shown to interfere with stroke treatment. tPA alone will also be studied since it is standard of care yet the safety and therapeutic window is not known in pregnancy or PE. It is our hope that the results of this project will lead to better treatment of stroke in pregnancy.
项目摘要 在美国,妊娠期中风是一个主要的健康问题,其发病率是中风率的3倍 在可比较的非妊娠女性中。妊娠相关的中风对一个人有着深远的和毁灭性的影响。 妇女的生活和照顾子女的能力。使公众健康问题更加复杂 在美国,与怀孕有关的中风正在上升。妊娠期中风风险增加 在很大程度上是由先兆子痫(PE)的合并症驱动的,PE是一种高血压疾病, 所有怀孕。事实上,超过1/3的妊娠相关性卒中患者合并PE, 中风风险是无PE女性的6倍。与这一建议相关的是,妊娠期卒中在很大程度上未被研究。 孕妇被排除在随机卒中临床试验之外,因此对 在这个人群中的治疗和结果。本R21提案旨在提供卒中方面急需的信息 妊娠和PE中的损伤和结局。我们的总体假设是母亲的大脑更容易受到 缺血和再灌注损伤比年龄匹配的非妊娠女性,这种易感性是进一步 加剧了PE。这一假设是基于我们公布的初步数据,表明增加 正常妊娠大鼠模型中的神经元兴奋性和脑损伤, 体育课此外,PE是一种高氧化应激和神经炎症的状态,可能会加剧中风损伤。 值得注意的是,尚不清楚妊娠和PE如何影响卒中结局。目标1将使用瞬态模型 在非妊娠、正常妊娠和PE大鼠中进行局灶性局部缺血以确定中风结果(梗塞,细胞损伤, 神经功能缺损和死亡率)以及损伤的促成因素,包括灌注缺损、侧支血流和 再灌注损伤(水肿和出血性转化)。Aim 2将采用临床相关剂量进行急性治疗 硫酸镁(MgSO 4)是一种安全有效的妊娠治疗方法,已使用数十年, 防止大脑过度兴奋和癫痫发作。MgSO 4是一种钙拮抗剂,可防止谷氨酸诱导的 这可能有助于预防妊娠期中风损伤和PE(一种兴奋性毒性状态)。 重要的是,我们将使用硫酸镁与组织纤溶酶原激活剂(tPA)的组合,因为tPA已被证明 干扰中风治疗也将单独研究tPA,因为它是标准护理,但安全性和 妊娠或PE的治疗窗未知。我们希望这个项目的结果将导致 更好地治疗妊娠期中风。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marilyn J Cipolla其他文献

STRUCTURAL AND FUNCTIONAL DIFFERENCES OF PLACENTAL COMPARED TO MYOENDOMETRIAL ARTERIES OF LATE GESTATION RABBITS. † 1193
妊娠期晚期兔子胎盘与肌层子宫内膜动脉的结构和功能差异。†1193
  • DOI:
    10.1203/00006450-199604001-01215
  • 发表时间:
    1996-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Marilyn J Cipolla;Nancy Binder
  • 通讯作者:
    Nancy Binder
Angiotensin II Vasodilates both Placental and Myoendometrial Arteries from Late Gestation Rabbits in Vitro † 981
  • DOI:
    10.1203/00006450-199804001-01002
  • 发表时间:
    1998-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Marilyn J Cipolla;Nancy D Binder
  • 通讯作者:
    Nancy D Binder

Marilyn J Cipolla的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marilyn J Cipolla', 18)}}的其他基金

Hippocampal arteriole remodeling and brain injury in preeclampsia and eclampsia
先兆子痫和子痫的海马小动脉重塑和脑损伤
  • 批准号:
    9919008
  • 财政年份:
    2018
  • 资助金额:
    $ 42.9万
  • 项目类别:
Hippocampal arteriole remodeling and brain injury in preeclampsia and eclampsia
先兆子痫和子痫的海马小动脉重塑和脑损伤
  • 批准号:
    9765427
  • 财政年份:
    2018
  • 资助金额:
    $ 42.9万
  • 项目类别:
Hippocampal arteriole remodeling and brain injury in preeclampsia and eclampsia
先兆子痫和子痫的海马小动脉重塑和脑损伤
  • 批准号:
    10163278
  • 财政年份:
    2018
  • 资助金额:
    $ 42.9万
  • 项目类别:
Hippocampal arteriole remodeling and brain injury in preeclampsia and eclampsia
先兆子痫和子痫的海马小动脉重塑和脑损伤
  • 批准号:
    10404042
  • 财政年份:
    2018
  • 资助金额:
    $ 42.9万
  • 项目类别:
Targeting pial collaterals for acute stroke treatment
针对急性中风治疗的软脑膜侧支循环
  • 批准号:
    10309056
  • 财政年份:
    2015
  • 资助金额:
    $ 42.9万
  • 项目类别:
Targeting Parenchymal Arterioles in Acute Stroke Treatment
急性中风治疗中的靶向实质小动脉
  • 批准号:
    9266499
  • 财政年份:
    2015
  • 资助金额:
    $ 42.9万
  • 项目类别:
Targeting pial collaterals for acute stroke treatment
针对急性中风治疗的软脑膜侧支循环
  • 批准号:
    10592439
  • 财政年份:
    2015
  • 资助金额:
    $ 42.9万
  • 项目类别:
Targeting pial collaterals for acute stroke treatment
针对急性中风治疗的软脑膜侧支循环
  • 批准号:
    10412122
  • 财政年份:
    2015
  • 资助金额:
    $ 42.9万
  • 项目类别:
Cerebrovascular Function during Ischemia and Reperfusion
缺血和再灌注期间的脑血管功能
  • 批准号:
    7998847
  • 财政年份:
    2010
  • 资助金额:
    $ 42.9万
  • 项目类别:
Cerebral Arteriole Function during Hyperglycemic Stroke
高血糖中风期间的脑动脉功能
  • 批准号:
    7225202
  • 财政年份:
    2005
  • 资助金额:
    $ 42.9万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 42.9万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 42.9万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 42.9万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 42.9万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 42.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 42.9万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 42.9万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 42.9万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 42.9万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 42.9万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了